NDC 58066-7022

Diarrhea Response

Aloe Socotrina, Chamomilla, Cinchona Officinalis, Colocynthis, Colostrum, Croton Tiglium, Cuprum Arsenicosum, Gelsemium Sempervirens, Ipecacuanha, Nux Vomica, Phosphoricum Acidum, Podophyllum Peltatum, Veratrum Album

Diarrhea Response is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Beaumont Bio Med. The primary component is Aloe; Matricaria Recutita; Cinchona Officinalis Bark; Citrullus Colocynthis Fruit Pulp; Bos Taurus Colostrum; Croton Tiglium Seed; Cupric Arsenite; Gelsemium Sempervirens Root; Ipecac; Strychnos Nux-vomica Seed; Phosphoric Acid; Podophyllum; Veratrum Album Root.

Product ID58066-7022_0ddfb6a6-e5f0-472a-a4a1-789fbb71ea36
NDC58066-7022
Product TypeHuman Otc Drug
Proprietary NameDiarrhea Response
Generic NameAloe Socotrina, Chamomilla, Cinchona Officinalis, Colocynthis, Colostrum, Croton Tiglium, Cuprum Arsenicosum, Gelsemium Sempervirens, Ipecacuanha, Nux Vomica, Phosphoricum Acidum, Podophyllum Peltatum, Veratrum Album
Dosage FormLiquid
Route of AdministrationORAL
Marketing Start Date2011-09-08
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameBeaumont Bio Med
Substance NameALOE; MATRICARIA RECUTITA; CINCHONA OFFICINALIS BARK; CITRULLUS COLOCYNTHIS FRUIT PULP; BOS TAURUS COLOSTRUM; CROTON TIGLIUM SEED; CUPRIC ARSENITE; GELSEMIUM SEMPERVIRENS ROOT; IPECAC; STRYCHNOS NUX-VOMICA SEED; PHOSPHORIC ACID; PODOPHYLLUM; VERATRUM ALBUM ROOT
Active Ingredient Strength10 [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL; [hp_X]/59.2mL
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 58066-7022-7

59.2 mL in 1 BOTTLE, SPRAY (58066-7022-7)
Marketing Start Date2011-09-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58066-7022-7 [58066702207]

Diarrhea Response LIQUID
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2011-09-08
Inactivation Date2020-01-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.